Sanofi has agreed a €300 million collaboration with private equity investor Blackstone Life Sciences (BXLS) to advance its innovative treatment for multiple myeloma (MM)...
Health Canada has approved the recombinant Covid-19 vaccine produced by Canadian biotech Medicago that uses the pandemic adjuvant made by British pharma giant...
US drugmaker Eli Lilly is investing about $700 million to establish an institute for researching and developing genetic medicines at a new site in the Seaport area of...
After several delays, Sanofi and GlaxoSmithKline are preparing to submit data to regulatory authorities to support approval of their adjuvanted protein vaccine against...
French pharma Ipsen has entered into exclusive negotiations for the sale of its global consumer healthcare business to compatriot firm Mayoly Spindler. The move, said...
In the VAT 0002 extension trial investigating the safety and immunogenicity of the protein-based recombinant adjuvanted Covid-19 vaccine they are partly developing as a...
French drugmaker Sanofi is taking an equity stake worth $180 million in and entering a new strategic collaboration with artificial intelligence (AI) and precision...
An unusually acrimonious dispute has arisen over patents – in particular for Covid-19 vaccines – in the US. The row between vaccine maker Moderna and its mentor, the US...
French pharma Sanofi is investing $60 million in Gyroscope Therapeutics, a UK-based clinical-stage gene therapy company focused on eye diseases. Sanofi will initially...
US drugs giant Merck & Co. has signed a definitive agreement to acquire publicly traded US biotech Acceleron Pharma for $180 per share, yielding a total equity value of...
